FIELD: medicine, clinical pharmacology. SUBSTANCE: invention relates to methods of pharmacological correction of disturbances of energetic metabolism in the brain. Bergenia crassifolia leaves extract is used as a cerebroprotecting agent showing an antihypoxic and an antiradical activity. EFFECT: broadened assortment of agents for the brain protection, increased specific activity of an agent, decreased adverse effects due to toxicity elimination. 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
CEREBROPROTECTING AGENT IN ENCEPHALOPATHY | 1998 |
|
RU2141330C1 |
CEREBROPROTECTING AGENT AND METHOD OF ITS PREPARING | 2000 |
|
RU2180584C1 |
MIXTURE OF MEDICINAL PLANTS WITH ANTIOXIDANT ACTIVITY | 2016 |
|
RU2613171C1 |
AN ANTIHYPOXIC AGENT | 1996 |
|
RU2121357C1 |
CARDIOPROTECTIVE, ANTIARRHYTHMIC ANTI-ISHEMIC AGENT | 2007 |
|
RU2366426C2 |
METHOD OF TREATMENT OF PATIENT WITH CHRONIC ASIDEROTIC ANEMIA IN UTERUS BLEEDING | 1998 |
|
RU2148409C1 |
PREPARATION BEING OF ANTIHYPOXIC AND CYTOPROTECTOR ACTIVITIES AND APPLIED FOR DECREASING REMANTADIN TOXICITY AT TREATING GRIPPE INFECTION | 2005 |
|
RU2302236C2 |
COLLECTION OF HERBS OF NOOTROPIC ACTION | 2020 |
|
RU2740897C1 |
AGENT SHOWING NOOTROPIC AND ADAPTOGENIC EFFECT | 1998 |
|
RU2136292C1 |
METHOD FOR CARRYING OUT EXPERIMENTAL ENCEPHALOPATHY THERAPY | 2004 |
|
RU2284060C1 |
Authors
Dates
1999-11-20—Published
1998-06-17—Filed